Skip to main content
Top
Published in: Annals of Surgical Oncology 11/2006

01-11-2006

eRFA: Excision Followed by RFA—a New Technique to Improve Local Control in Breast Cancer

Authors: V. Suzanne Klimberg, MD, Julie Kepple, MD, Gal Shafirstein, PhD, Laura Adkins, MAP, Ronda Henry-Tillman, MD, Emad Youssef, MD, Jorge Brito, MD, Lori Talley, BS, Soheila Korourian, MD

Published in: Annals of Surgical Oncology | Issue 11/2006

Login to get access

Abstract

Introduction

Excision followed by RFA (eRFA) may allow improved cosmesis while ensuring negative margins in patients with breast cancer. This technique utilizes heat to create an additional tumor-free zone around the lumpectomy cavity. We hypothesized that eRFA will decrease the need for re-excision of inadequate margins.

Methods

Between July 2002 and January 2005, we conducted a multiphase trial of RFA of prophylactic mastectomy specimens and of women desiring lumpectomy. In both models, a lumpectomy was performed, the RFA probe was deployed 1 cm circumferentially into the walls of the lumpectomy cavity and maintained at 100°C for 15 min. Whole mount slides were used to measure the zone of ablation for ex vivo specimens. Hematoxylin and eosin staining of in vivo lumpectomy margins <3 mm was considered inadequate.

Results

Nineteen prophylactic mastectomy ablations revealed a consistent perimeter of ablation. Forty-one patients (mean age 63 ± 14 years) had an average tumor size of 1.6 ± 1.5 cm underwent in vivo eRFA, and 25% had inadequate margins: one focally positive, one <2 mm, eight <1 mm and one grossly positive. Only the grossly positive margin was re-excised. Overall complication rate of in vivo ablations was 7.5%. Twenty-four of 41 patients did not have post-eRFA XRT. No in-site local recurrences have occurred during a median follow-up of 24 months (12–45 months). Two patients have occurred elsewhere.

Conclusions

The ex vivo ablation model reliably created a 5–10 mm perimeter of ablation. In vivo, this zone reduced the need for re-excision for inadequate margins by 91% (10/11). Short-term follow-up suggests that eRFA could reduce re-excision surgery and local recurrence.
Literature
1.
go back to reference Mokbel K, Ahmed M, Nash A, Sacks N. Re-excision operations in nonpalpable breast cancer. J Surg Onc 1995;58(4):225–8 Mokbel K, Ahmed M, Nash A, Sacks N. Re-excision operations in nonpalpable breast cancer. J Surg Onc 1995;58(4):225–8
2.
go back to reference Clark K, Le MG, Sarrazin D, Lacombe MJ, Fontaine F, Travagli JP, May-Levine F. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institute Gustave-Roussy. Int J Radiat Oncol Biol Phys 1985; 11:137–45 Clark K, Le MG, Sarrazin D, Lacombe MJ, Fontaine F, Travagli JP, May-Levine F. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institute Gustave-Roussy. Int J Radiat Oncol Biol Phys 1985; 11:137–45
3.
go back to reference Hustreich DJ, Dunn JM, Armstrong JS, et al. Diagnostic and therapeutic aspects of fine wire localization biopsy for impalpable breast cancer. Br J Surg 1992; 79:1038–41 Hustreich DJ, Dunn JM, Armstrong JS, et al. Diagnostic and therapeutic aspects of fine wire localization biopsy for impalpable breast cancer. Br J Surg 1992; 79:1038–41
4.
go back to reference Singletary ES. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002; 184:383–93CrossRefPubMed Singletary ES. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002; 184:383–93CrossRefPubMed
5.
go back to reference Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N. Fifteen-year prognostic discriminants for invasive breast carcinoma: national surgical adjuvant breast and bowel project protocol-06. Cancer 2001; 91(Suppl 8);1679–87CrossRefPubMed Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N. Fifteen-year prognostic discriminants for invasive breast carcinoma: national surgical adjuvant breast and bowel project protocol-06. Cancer 2001; 91(Suppl 8);1679–87CrossRefPubMed
6.
go back to reference Fisher B, Anderson S, Bryant J et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347(16):1270–1CrossRef Fisher B, Anderson S, Bryant J et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347(16):1270–1CrossRef
7.
go back to reference Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996; 62:596–602 Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996; 62:596–602
8.
go back to reference Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003; 98:697–702CrossRefPubMed Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003; 98:697–702CrossRefPubMed
9.
go back to reference Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345:1378–87CrossRefPubMed Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345:1378–87CrossRefPubMed
10.
go back to reference Malmstrom P, Holmberg L, Anderson H, et al, for the Swedish Breast Cancer Group. Breast conservation surgery, with or without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer 2003; 39:1690–7CrossRefPubMed Malmstrom P, Holmberg L, Anderson H, et al, for the Swedish Breast Cancer Group. Breast conservation surgery, with or without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer 2003; 39:1690–7CrossRefPubMed
11.
go back to reference Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993; 328:1587–91CrossRefPubMed Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993; 328:1587–91CrossRefPubMed
12.
go back to reference Clark RM, Whelan T, Levine M, Roberts R, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 1996; 88:1659–64PubMed Clark RM, Whelan T, Levine M, Roberts R, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 1996; 88:1659–64PubMed
13.
go back to reference Carter D. Margins of “lumpectomy” for breast cancer. Hum Pathol 1966; 17:330–2 Carter D. Margins of “lumpectomy” for breast cancer. Hum Pathol 1966; 17:330–2
14.
go back to reference Jardines L, Fowble B, Schultz D, Mackie J, Buzby J, Torosian M, Daly J, Weiss M, Orel S, Rosata E. Factors associated with a positive reexcision after excisional biospy for invasive breast cancer. Surgery 1995; 118(5):803–9CrossRefPubMed Jardines L, Fowble B, Schultz D, Mackie J, Buzby J, Torosian M, Daly J, Weiss M, Orel S, Rosata E. Factors associated with a positive reexcision after excisional biospy for invasive breast cancer. Surgery 1995; 118(5):803–9CrossRefPubMed
15.
go back to reference Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys 2004; 60(3):722–30CrossRefPubMed Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys 2004; 60(3):722–30CrossRefPubMed
16.
go back to reference Wazer DE, DePetrillo T, Schmidt-Ullrich R, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1992; 10:356–63PubMed Wazer DE, DePetrillo T, Schmidt-Ullrich R, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1992; 10:356–63PubMed
17.
go back to reference Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservation surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 2002; 80:121–8CrossRefPubMed Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservation surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 2002; 80:121–8CrossRefPubMed
18.
go back to reference Vicini FA, Baglan KL, Kestin LL, et al. Accelerated treatment of breast cancer. J Clin Oncol 2001; 19:1993–2001PubMed Vicini FA, Baglan KL, Kestin LL, et al. Accelerated treatment of breast cancer. J Clin Oncol 2001; 19:1993–2001PubMed
19.
go back to reference Kini V. Balloon breast brachytherapy – Review of current data. Brachytherapy 2005; 4(3):224–9CrossRef Kini V. Balloon breast brachytherapy – Review of current data. Brachytherapy 2005; 4(3):224–9CrossRef
20.
go back to reference Wood BJ, Ramkaransingh JR, Fojo T, Walther MM, Libutti SK. Percutaneous tumor ablation with radiofrequency. Cancer 2002; 94(2):443–51CrossRefPubMed Wood BJ, Ramkaransingh JR, Fojo T, Walther MM, Libutti SK. Percutaneous tumor ablation with radiofrequency. Cancer 2002; 94(2):443–51CrossRefPubMed
21.
go back to reference Jeffrey SS, Birdwell RL, Ikeda DM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg 1999; 134:1064–8CrossRefPubMed Jeffrey SS, Birdwell RL, Ikeda DM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg 1999; 134:1064–8CrossRefPubMed
22.
go back to reference Izzo F, Thomas R, Delrio P, et al. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer 2001; 92:2036–44CrossRefPubMed Izzo F, Thomas R, Delrio P, et al. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer 2001; 92:2036–44CrossRefPubMed
23.
go back to reference Fornage BD, Sneige N, Ross MI, et al. Small ( 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 2004; 231:215–24PubMed Fornage BD, Sneige N, Ross MI, et al. Small ( 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 2004; 231:215–24PubMed
24.
go back to reference Burak WE Jr, Agnese DM, Povoski SP, et al. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer 2003; 98:1369–76CrossRefPubMed Burak WE Jr, Agnese DM, Povoski SP, et al. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer 2003; 98:1369–76CrossRefPubMed
25.
go back to reference Hayashi AH, Silver SF, van der Westhuizen NG, et al. Treatment of invasive breast carcinoma with ultra-sound-guided radiofrequency ablation. Am J Surg 2003; 185:429–35CrossRefPubMed Hayashi AH, Silver SF, van der Westhuizen NG, et al. Treatment of invasive breast carcinoma with ultra-sound-guided radiofrequency ablation. Am J Surg 2003; 185:429–35CrossRefPubMed
26.
go back to reference Singletary SE, Fornage BD, Sneige N, et al. Radiofrequency ablation of early-stage invasive breast tumors: an overview. Cancer 2002; 8:177–80CrossRef Singletary SE, Fornage BD, Sneige N, et al. Radiofrequency ablation of early-stage invasive breast tumors: an overview. Cancer 2002; 8:177–80CrossRef
27.
go back to reference Noguchi M, Earashi M, Fujii H, et al. Radiofrequency ablation of small breast cancer followed by surgical resection. J Surg Oncol 2006; 93:120–8CrossRefPubMed Noguchi M, Earashi M, Fujii H, et al. Radiofrequency ablation of small breast cancer followed by surgical resection. J Surg Oncol 2006; 93:120–8CrossRefPubMed
28.
go back to reference Celis JE, Celis A. Cell cycle-dependent variation in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA 1985; 82:3262–6CrossRefPubMed Celis JE, Celis A. Cell cycle-dependent variation in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA 1985; 82:3262–6CrossRefPubMed
29.
go back to reference Korourian S, Klimberg S, Henry-Tillman R, et al. Assessment of proliferating cell nuclear antigen activity using digital image analysis in breast carcinoma following magnetic resonance-guided interstitial laser photocoagulation. Breast J 2003; 9(5):409–13CrossRefPubMed Korourian S, Klimberg S, Henry-Tillman R, et al. Assessment of proliferating cell nuclear antigen activity using digital image analysis in breast carcinoma following magnetic resonance-guided interstitial laser photocoagulation. Breast J 2003; 9(5):409–13CrossRefPubMed
30.
go back to reference Smith TE, Lee D, Turner BC, et al. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000; 48:1281–9CrossRefPubMed Smith TE, Lee D, Turner BC, et al. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000; 48:1281–9CrossRefPubMed
31.
go back to reference Lim M, Bellon JR, Gelman R, et al. A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer. Int J Radiat Oncol Biol Phys 2006; 65(4):1149–54CrossRefPubMed Lim M, Bellon JR, Gelman R, et al. A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer. Int J Radiat Oncol Biol Phys 2006; 65(4):1149–54CrossRefPubMed
32.
go back to reference Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347:1233–41CrossRefPubMed Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347:1233–41CrossRefPubMed
33.
go back to reference Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992; 11:19–25PubMed Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992; 11:19–25PubMed
34.
go back to reference Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347:1227–32CrossRefPubMed Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347:1227–32CrossRefPubMed
35.
go back to reference Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomized trial on 1,973 patients. Eur J Cancer 1995; 31A:1574–9CrossRefPubMed Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomized trial on 1,973 patients. Eur J Cancer 1995; 31A:1574–9CrossRefPubMed
36.
go back to reference van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000; 92:1143–50CrossRefPubMed van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000; 92:1143–50CrossRefPubMed
37.
go back to reference van Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr 1992; 11:15–18PubMed van Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr 1992; 11:15–18PubMed
38.
go back to reference Jacobsen JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995; 332:907–11CrossRef Jacobsen JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995; 332:907–11CrossRef
39.
go back to reference Sarrazin D, La MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989; 14:177–84CrossRefPubMed Sarrazin D, La MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989; 14:177–84CrossRefPubMed
40.
41.
go back to reference Haga S, Makita M, Shimiza T, et al. Histopathological study of local residual carcinoma after simulated lumpectomy. Surg Today 1995; 25:329–33CrossRefPubMed Haga S, Makita M, Shimiza T, et al. Histopathological study of local residual carcinoma after simulated lumpectomy. Surg Today 1995; 25:329–33CrossRefPubMed
42.
go back to reference Holaday WJ, Assor D. Ten thousand consecutive frozen sections: a retrospective study focusing on accuracy and quality control. Am J Clin Pathol 1974; 61:769–77PubMed Holaday WJ, Assor D. Ten thousand consecutive frozen sections: a retrospective study focusing on accuracy and quality control. Am J Clin Pathol 1974; 61:769–77PubMed
43.
go back to reference Klimberg VS, Westbrook KC, Korourian S. Use of touch preps for diagnosis and evaluation of surgical margins in breast cancer. Ann Surg Oncol 1998; 5:220–6CrossRefPubMed Klimberg VS, Westbrook KC, Korourian S. Use of touch preps for diagnosis and evaluation of surgical margins in breast cancer. Ann Surg Oncol 1998; 5:220–6CrossRefPubMed
44.
go back to reference Freedman GM, Fowble BL, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radition have an increased risk of breast recurrence that is delyed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999; 44:1005–15CrossRefPubMed Freedman GM, Fowble BL, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radition have an increased risk of breast recurrence that is delyed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999; 44:1005–15CrossRefPubMed
45.
go back to reference Early Breast Cancer Trialist’s Collaborative Group. Lancet 2005; 366;2087–105 Early Breast Cancer Trialist’s Collaborative Group. Lancet 2005; 366;2087–105
46.
go back to reference Veronesi U, Volterrani F, Luini A, et al. Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 1990; 26(6):671–3PubMedCrossRef Veronesi U, Volterrani F, Luini A, et al. Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 1990; 26(6):671–3PubMedCrossRef
47.
go back to reference Arcangeli G, Micheli A, D’Angelo L, Giovinazzo G, Arcangeli G, Tersigni R, Comandini E, Scala T, Lopez M, Mauri M, D’Aprile M. Conservative surgery and radiotherapy in early stage breast cancer: a comparison between tumourectomy and quadrantectomy. Radiother Oncol 1998; 46(1):39–45CrossRefPubMed Arcangeli G, Micheli A, D’Angelo L, Giovinazzo G, Arcangeli G, Tersigni R, Comandini E, Scala T, Lopez M, Mauri M, D’Aprile M. Conservative surgery and radiotherapy in early stage breast cancer: a comparison between tumourectomy and quadrantectomy. Radiother Oncol 1998; 46(1):39–45CrossRefPubMed
48.
go back to reference Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 2001; 12:997–1003CrossRefPubMed Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 2001; 12:997–1003CrossRefPubMed
49.
go back to reference Holli K, Saaristo R, Isola J, et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: Results of a randomized study. Br J Cancer 2001; 84:164–9CrossRefPubMed Holli K, Saaristo R, Isola J, et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: Results of a randomized study. Br J Cancer 2001; 84:164–9CrossRefPubMed
50.
go back to reference Liljegren G, Holmberg L, Bergh J, et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 1999; 17:2326–33PubMed Liljegren G, Holmberg L, Bergh J, et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 1999; 17:2326–33PubMed
51.
go back to reference Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002; 20(20):4141–9CrossRefPubMed Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002; 20(20):4141–9CrossRefPubMed
52.
go back to reference Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-T2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985; 56(5);979–90CrossRefPubMed Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-T2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985; 56(5);979–90CrossRefPubMed
53.
go back to reference Ohtake T, Kimijima I, Fukushima T, et al. Computer-assisted complete three-dimensional reconstruction of the mammary ductal/lobular systems: implications of ductal anastomoses for breast-conserving surgery. Cancer 2001; 91(12):2263–72CrossRefPubMed Ohtake T, Kimijima I, Fukushima T, et al. Computer-assisted complete three-dimensional reconstruction of the mammary ductal/lobular systems: implications of ductal anastomoses for breast-conserving surgery. Cancer 2001; 91(12):2263–72CrossRefPubMed
54.
go back to reference Ohtake T, Abe R, Kimijima I, et al. Intraductal extension of primary invasive breast carcinoma treated by brest-conservative surgery. Computer graphic three-dimensional reconstruction f the mammary duct-lobular systems. Cancer 1995; 76(1):32–45CrossRefPubMed Ohtake T, Abe R, Kimijima I, et al. Intraductal extension of primary invasive breast carcinoma treated by brest-conservative surgery. Computer graphic three-dimensional reconstruction f the mammary duct-lobular systems. Cancer 1995; 76(1):32–45CrossRefPubMed
55.
go back to reference Ribeiro GG, Magee B, Swindell R, et al. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) 1993; 5:278–83 Ribeiro GG, Magee B, Swindell R, et al. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) 1993; 5:278–83
56.
go back to reference Veronesi U, Orecchia R, Luini A, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 2001; 37:2178–83CrossRefPubMed Veronesi U, Orecchia R, Luini A, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 2001; 37:2178–83CrossRefPubMed
Metadata
Title
eRFA: Excision Followed by RFA—a New Technique to Improve Local Control in Breast Cancer
Authors
V. Suzanne Klimberg, MD
Julie Kepple, MD
Gal Shafirstein, PhD
Laura Adkins, MAP
Ronda Henry-Tillman, MD
Emad Youssef, MD
Jorge Brito, MD
Lori Talley, BS
Soheila Korourian, MD
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 11/2006
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9151-4

Other articles of this Issue 11/2006

Annals of Surgical Oncology 11/2006 Go to the issue